Interview reveals Sarah Teichmann's insights on genomics and artificial intelligence in improving immunity and research.
Sarah Teichmann is a professor at the University of Cambridge, where she leads a research group that uses a combination of genomics, artificial intelligence (AI), and bioinformatics to further understand various aspects of immunity. She is also one of the co-founders of the Human Cell Atlas, a nonexecutive director of 10x Genomics, an advisor for multiple biotech startups, and now a part-time Vice President, Translational Research at GlaxoSmithKline (GSK). We spoke to Sarah about expanding beyond academic science in your career, dealing with uncertainty in the workplace, and being able to carve out time for yourself despite having multiple demands on your time.
No takes yet. Share an insight, caveat, or question.
Lucie Van Emmenis (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: